Alzheimer's Association International Conference | July 22-28, Toronto, Canada
July 22-28, Toronto, Canada
July 22-28, Toronto, Canada
Scientific Sessions
Below, you'll find a list of Invited Plenary and Symposia sessions featured during AAIC 2016.
10:30 - 11 a.m.
Association Welcome
Session: PL-01-01
11 - 11:30 a.m.
Preclinical to Clinical Translation for Tau Therapeutics
David Holtzman
Washington University in St. Louis,
St. Louis, Mo., United States
Session: PL-01-02
10:30 - 11 a.m.
Exercise and Memory Decline
Laura Baker
Wake Forest School of Medicine,
Winston Salem, N.C., United States
Session: PL-02-01
11 - 11:30 a.m.
Role of Peripheral Inflammation in Cognitive Impairment and Alzheimer's Disease
Gabriela Constantin
University of Verona, Verona, Italy
Session: PL-02-02
10:30 - 11 a.m.
Inge Grundke-Iqbal Lecture for Alzheimer's Research
Exosomes and Microglia in Tau Propagation
Tsuneya Ikezu
Boston University School of Medicine
Boston, Mass., United States
Session: PL-03-01
11 - 11:30 a.m.
A Moving Target? Dementia in Changing Older Populations
Carol Brayne
University of Cambridge,
Cambridge, United Kingdom
Session: PL-03-02
10:30 - 11 a.m.
The Science Behind Traumatic Brain Injury and Its Relationship to Dementia
Cheryl Wellington
University of British Columbia Vancouver
Vancouver, British Columbia, Canada
Session: PL-04-01
11 - 11:30 a.m.
Genomic Analysis of Neurodegeneration Gives Clues to Pathways to Selective Cell Loss: The Hypothesis of the Catastrophic Cliff of Neuron Failure
John Hardy
University College London Institute of Neurology,
London, United Kingdom
Session: PL-04-02
10:30 - 11 a.m.
The Challenges Ahead for PET Imaging of Progressive Proteinopathies
Victor Villemagne
The Florey Institute of Neuroscience and Mental Health,
Parkville, Australia
Session: PL-05-01
11 - 11:30 a.m.
Nexus of Alzheimer's and Cancer
Jane Ann Driver
Brigham and Women's Hospital,
Boston Mass., United States;
Harvard Medical School,
Boston, Mass., United States
Session: PL-05-02
PRESENTATIONS
SPEAKERS
Differences Between Men and Women in the Risk of Dementia
Michelle Mielke
Mayo Clinic, Rochester,
Minn., United States
Sex-Specific Drivers of Alzheimer's Disease Risk and Resilience
Timothy Hohman
Vanderbilt University Nashville, Tenn. United States
Sex Differences in the Brain and Implications for Alzheimer's Disease
Gillian Einstein
University of Toronto,
Toronto, ON, Canada
PRESENTATIONS
SPEAKERS
Evidence-Based Computerized Cognitive Training: What, How, When & Where
Michael Valenzuela
University of Sydney,
South Wales, Australia
The ACTIVE Study: What We Have Learned and What is Next?
Jerri Edwards
University of South Florida,
Tampa, Fla., United States
Functional Neuroimaging in Trials of Cognition Focused Interventions
Sylvie Belleville
Institut universitaire de gériatrie de Montréal,
Montreal, QC, Canada
Unpacking Active Ingredients in Complex Cognition-focused Interventions for Older Adults at Risk of Dementia: Are Existing Classifications Still Relevant?
Alex Bahar-Fuchs
The Australian National University,
Canberra, Australia
PRESENTATIONS
SPEAKERS
Brain Aging and Pathology in Older African-Americans
Lisa Barnes
Rush University Medical Center,
Chicago, Ill., United States
Indigenous Australians: Lifespan, Health, Aging and Dementia
G A (Tony) Broe
The University of New South Wales,
Sydney, Australia
Past, Present and Future of the 10/66 Dementia Research Group in Low and Middle Income Countries
Ana Sosa-Ortiz
Dementia Laboratory National Institute of Neurology and Neurosurgery,
Mexico City, Mexico
Role of Cerebrovascular Disease and Vascular Pathology on Racial Ethnic Differences in Rates of Alzheimer's Disease and Dementia
Raj Kalaria
Newcastle University,
Newcastle, United Kingdom
PRESENTATIONS
SPEAKERS
Gene Expression, Pathology and Genetic Epidemiology in Large Population-based Studies
Anita DeStefano
Boston University,
Boston, Mass., United States
Added Value of the Combined Biobank/MRI Data in the Italian Project on the Epidemiology of Alzheimer's Disease: (IPREA) Cohort
Emanuele Scafato
Istituto Superiore di Sanità,
Rome, Italy
Predicted Value of Biomarker/MRI Results in the Three City Study
Stéphanie Debette
University of Bordeaux,
Bordeaux, France
Prevalence of MRI Abnormalities in the Framingham Study
Charles DeCarli
University of California, Davis,
Davis, Calif., United States
PRESENTATIONS
SPEAKERS
Lessons from the Midbrain
Lorenz Studer
Memorial-Sloan Kettering Cancer Center,
New York, N.Y.,
United States
A Novel Human iPSC-Based Model of Alzheimer's Disease Generated by Knock-in of Early-Onset AD Mutations Displays Disease-Relevant, Zygosity-Dependent Phenotypes
Dylan Kwart
The Rockefeller University,
New York, N.Y.,
United States
Modelling Microglia with Human Pluripotent Stem Cells
Sally Cowley
Oxford Stem Cell Institute,
Oxford, United Kingdom
PRESENTATIONS
SPEAKERS
Cross Sectional Studies of Plasma Proteomic Biomarkers Relating to PET Amyloid and CSF Amyloid and Tau
Alison Baird
University of Oxford,
Oxford, United Kingdom
Progress in Standardization and Implementation of CSF Biomarkers in Clinical Trials and Routine Practice
Leslie Shaw
University of Pennsylvania,
Philadelphia, Pa.,
United States
Correlation of Plasma Proteomic Biomarkers with Cerebral Amyloid in the AIBL Longitudinal Study of Aging
Ralph Martins
Sir James McCusker
Alzheimer's Disease Research Unit
(Hollywood Private Hospital),
Perth, Australia
CSF AD Biomarkers and Amyloid PET Imaging Give Us Similar Information in Prodromal Alzheimer's Disease
Oskar Hansson
Lund University,
Lund, Sweden
PRESENTATIONS
SPEAKERS
Alzheimer's Disease Sequencing Project: Case-Control Analyses
Adam Naj
University of Pennsylvania,
Philadelphia, Pa.,
United States
Alzheimer's Disease Sequencing Project: Family-Based Analyses
Ellen Wijsman
University of Washington,
Seattle, Wash.,
United States
Accelerating Medicines Partnership: Co-Expression Networks
Bin Zhang
Icahn School of Medicine at Mount Sinai,
New York, New York,
United States
Accelerating Medicines Partnership: Identifying Therapeutic Targets for Alzheimer's Disease with Comparative Transcriptomics
Nilufer Ertekin-Taner
Mayo Clinic,
Jacksonville, Fla.,
United States
PRESENTATIONS
SPEAKERS
Macroautophagy Therapeutic Strategies for Neurodegenerative Conditions
Fiona Menzies
University of Cambridge, Cambridge, United Kingdom
Targeting of Chaperone Activity for the Treatment of Alzheimer's Disease
Laura Blair
University of South Florida,
Tampa, Fla., United States
Therapeutic Opportunities for the Modulation of Myeloid Cells for the Treatment of Alzheimer's Disease
Frank Heppner
Charité - Universitätsmedizin
Berlin, Berlin, Germany
TREM2 Biology: Potential Therapeutic Targeting of Microglia for Alzheimer's Disease Treatment
Marco Colonna
Washington University in St. Louis,
St. Louis, Mo., United States
Don't miss this new innovative aspect of the AAIC program highlighting basic dementia science.
Join other students and postdocs for networking meet and greets with experts in the field.
Join the Conversation #AAIC16